BIRC5 and esophageal cancer: Previous researches have indicated that survivin is overexpressed in esophageal cancer cells and the expression of survivin sustains growth and confers resistance to chemotherapy in esophageal cancer cells (Hui et al., 2012; Zhou et al., 2018; Yan et al., 2020), which suggests survivin plays a significant role in esophageal cancer.